Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy, safety, and tolerability of
Levomilnacipran ER versus placebo in the treatment of outpatients with major depressive
disorder